| Closing Price ($) | Shares Out (MM) | Market Cap ($MM) |
| $0.00 | 0 | $0 |
| 10-Q | 2019-09-30 | Quarter: 2019-09-30 |
| 10-Q | 2019-06-30 | Quarter: 2019-06-30 |
| 10-Q | 2019-03-31 | Quarter: 2019-03-31 |
| 10-K | 2018-12-31 | Annual: 2018-12-31 |
| 10-Q | 2018-09-30 | Quarter: 2018-09-30 |
| 10-Q | 2018-06-30 | Quarter: 2018-06-30 |
| 10-Q | 2018-03-31 | Quarter: 2018-03-31 |
| 10-K | 2017-12-31 | Annual: 2017-12-31 |
| 10-Q | 2017-09-30 | Quarter: 2017-09-30 |
| 10-Q | 2017-06-30 | Quarter: 2017-06-30 |
| 10-Q | 2017-03-31 | Quarter: 2017-03-31 |
| 10-K | 2016-12-31 | Annual: 2016-12-31 |
| 8-K | 2019-02-05 | Enter Agreement, Leave Agreement, Exhibits |
| Comparables ($MM Annual) | Ticker | Market Cap | Assets | Liabilities | Revenue | Gross Profit | Net Income | EBITDA | EV |
| Ryanair Holdings | RYAA | 13,251 | 8,036 | 0 | 0 | 0 | 0 | -35 | |
| Lingo Media | LMDC | 1 | 1 | 0 | 0 | 0 | 0 | -0 | |
| China Crawfish | CACA | 0 | 0 | 0 | 0 | -0 | -0 | -0 | |
| Apollo Education | APOL | 1,063 | 1,955 | 886 | 2,000 | 0 | -20 | 98 | 579 |
| Granite Real Estate | GRP | ||||||||
| Weyland Tech | WEYL | 11 | 5 | 29 | -1 | -4 | -4 | -5 | |
| Mirenco | MREO | ||||||||
| Baynon | BNON | 0 | 0 | 0 | 0 | -0 | -0 | 0 | |
| Green Planet Bio Engineering | GPLB | 3 | 0 | 0 | 0 | 0 | -0 | -0 | 3 |
| G-Mes Holdings | GMES | 1 | 1 | 1 | 1 | 0 | 0 | -0 | |
| Immune Therapeutics | IMUN | 0 | 0 | 13 | 0 | 0 | -5 | -5 | -0 |
| Therapeutic Solutions | TSOI | 0 | 0 | 2 | 0 | 0 | -2 | -1 | 0 |
| Blue Sphere | BLSP | 1 | 44 | 87 | 8 | 3 | -14 | -14 | 9 |
| Frontier Digital Media Group | FDMG | 0 | 0 | 0 | 0 | -0 | -0 | -0 | |
| Stem Holdings | STEMH | 41 | 6 | 1 | 0 | -8 | -7 | -5 | |
| MWF Global | MWF | 0 | 0 | -0 | -0 | -0 | |||
| SpringWorks | SWTX | ||||||||
| Clean Coal Technologies | CCTC | 0 | 17 | 0 | 0 | -6 | -3 | 1 | |
| Brighthouse Life Insurance Co of Ny | BHNY | 9,066 | 8,030 | 237 | 0 | 0 | 3 | -190 | |
| Imine | JRVS | 6 | 0 | 1 | 0 | 0 | -2 | -2 | 6 |
| Balance Sheet ($MM) | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
| Cash | 19 | 31 | 34 | 92 | 86 | 92 | 116 | 140 | 120 | 209 | 190 |
| Accounts Receivable | |||||||||||
| Inventory | |||||||||||
| PP&E | |||||||||||
| Assets | 7,633 | 7,925 | 8,059 | 8,278 | 8,486 | 8,390 | 8,403 | 8,519 | 8,130 | 8,757 | 9,066 |
| Accounts Payable | |||||||||||
| Long-Term Debt | |||||||||||
| Liabilities | 6,936 | 7,281 | 7,377 | 7,600 | 7,643 | 7,591 | 7,624 | 7,763 | 7,293 | 7,801 | 8,030 |
| Stockholders' Equity | 697 | 644 | 681 | 678 | 843 | 799 | 779 | 757 | 837 | 956 | 1,036 |
| Income Statement ($MM) | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
| Revenue | -89 | 48 | 12 | 41 | 1 | 24 | 18 | 112 | 35 | 72 | |
| Cost of Revenue | |||||||||||
| Gross Profit | |||||||||||
| R&D | |||||||||||
| SG&A | |||||||||||
| Tax | 0 | 11 | 12 | -54 | 0 | 0 | 0 | -2 | 0 | 4 | |
| Net Income | |||||||||||
| Cash Flow ($MM) | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
| Cash Operating | 11 | 58 | 31 | 53 | 24 | 31 | 32 | 22 | 4 | -7 | |
| Cash Investing | 22 | -90 | -17 | -200 | -113 | -92 | -103 | -106 | -80 | -149 | |
| Cash Financing | -22 | 35 | 44 | 141 | 95 | 85 | 96 | 64 | 165 | 138 |